Moore Capital Management »

Springworks Therapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $11M 239k 46.99

More positions owned by Moore Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Bank of America Corporation (BAC)
Amazon (AMZN)
Freeport-mcmoran CL B Call Option (FCX)
Ally Financial (ALLY)
Aon Shs Cl A (AON)
Spotify Technology S A SHS (SPOT)
Netflix (NFLX)

View all positions for Moore Capital Management

Top funds holding Springworks Therapeutics

Morgan Stanley
DekaBank Deutsche Girozentrale
E Fund Management
Advisor Group Holdings
FNY Investment Advisers
FTB Advisors
Huntington National Bank

View all funds holding Springworks Therapeutics